MLPA® Kits

For a description how to create and adapt MLPA Kits, that are not available on this page, please have a look at our User Manual MLPA.

Import of SALSA MLPA® kit descriptions via the SEQUENCE Pilot operation "Mixes [master file] / button [Import]".

Mix
Version
Date
Region
Application
Vs. 05
08-08-2014
various Wilms' tumour
Vs. 07
28-04-2017
various Wilms' tumour
Vs. 02
21-01-2010
COL11A1 Marshall, type II Stickler syndromes
Vs. 03
14-01-2012
COL11A1 Marshall, type II Stickler syndromes
P381-A2 Vs. 07 07-02-2014 COL11A1 Marshall, type II Stickler syndromes
P381-A3 Vs. 08 20-06-2017 COL11A1 Marshall, type II Stickler syndromes
Vs. 02
21-01-2010
COL11A1 Marshall, type II Stickler syndromes
Vs. 03
14-01-2012
COL11A1 Marshall, type II Stickler syndromes
Vs. 07 07-02-2014 COL11A1 Marshall, type II Stickler syndromes
Vs. 08 20-06-2017 COL11A1 Marshall, type II Stickler syndromes
Vs. 03
10-05-2013
various T-ALL
Vs. 01
24-06-2011
IHH, HHIP, NPPC, HMGA2, ADAMTSL3 Human Height
Vs. 04
01-03-2013
IHH, HHIP, NPPC, HMGA2, ADAMTSL3 Human Height
Vs. 01
29-03-2011
9p24.3 HIES
Vs. 03
02-12-2012
9p24.3 HIES
Vs. 04
19-06-2015
9p24.3 HIES
Vs. 01
29-03-2011
17q21.2, 9p24.3 HIES
Vs. 04
19-06-2015
17q21.2, 9p24.3 HIES
Vs. 01
19-05-2011
NPHP1 2q13 Familial juvenile nephronophthisis
P387-A1 Vs. 02 08-01-2012 NPHP1 2q13 Familial juvenile nephronophthisis
P387-A1 Vs. 03 02-12-2012 NPHP1 2q13 Familial juvenile nephronophthisis
P387-A2 Vs. 04 19-06-2015 NPHP1 2q13 Familial juvenile nephronophthisis
Vs. 01
30-03-2011
RNASEHB, C & D genes, TREX1, SAMHD1 Aicardi-Goutieres Syndrome
Vs. 02
02-12-2012
RNASEHB, C & D genes, TREX1, SAMHD1 Aicardi-Goutieres Syndrome
P388-A2 Vs. 03
24-06-2015
RNASEHB, C & D genes, TREX1, SAMHD1 Aicardi-Goutieres Syndrome
Vs. 02
06-09-2011
MLL2 gene Kabuki syndrome
P389-A1 Vs. 03 25-01-2012 MLL2 gene Kabuki syndrome
P389-A1 Vs. 05 02-12-2012 MLL2 gene Kabuki syndrome
P389-A1 Vs. 06 29-06-2015 MLL2 gene Kabuki syndrome
Vs. 02 02-12-2012 TBX4, TBX2, 17q23.1-q23.2 Small Patella Syndrome
Vs. 03 30-11-2012 LAMA2 CMD, Merosin-deficient
P391-A2 Vs. 05 04-11-2015 LAMA2 CMD, Merosin-deficient
Vs. 03 30-11-2012 LAMA2 CMD, Merosin-deficient
P392-A2 Vs.05 04-11-2015 LAMA2 CMD, Merosin-deficient
Vs. 01
06-10-2011
SLC26A3 7q31.1 Congenital Chloride Diarrhoea
Vs. 02
30-11-2012
SLC26A3 7q31.1 Congenital Chloride Diarrhoea
Vs. 01
17-05-2011
MYO5B 18q21.1 Microvillus Inclusion Disease (MVID)
Vs. 03
30-11-2012
MYO5B 18q21.1 Microvillus Inclusion Disease (MVID)
Vs. 01
15-11-2011
MEF2C 5q14.3, FOXG1 14q12 mental retardation
Vs. 02
30-11-2012
MEF2C 5q14.3, FOXG1 14q12 mental retardation
Vs. 03
02-04-2014
MEF2C 5q14.3, FOXG1 14q12 mental retardation
Vs. 02
26-12-2011
SHANK2 11q13.3 Autism-spectrum disorder
Vs. 03
30-11-2012
SHANK2 11q13.3 Autism-spectrum disorder
Vs. 04
11-03-2015
SHANK2 11q13.3 Autism-spectrum disorder
Vs. 02
30-11-2012
CACNA1S, SCN4A nondystrophic myotonias and primary periodic paralyses
Vs. 03
30-06-2015
CACNA1S, SCN4A nondystrophic myotonias and primary periodic paralyses
Vs. 04
03-03-2016
CACNA1S, SCN4A nondystrophic myotonias and primary periodic paralyses
Vs. 05
15-08-2016
CACNA1S, SCN4A nondystrophic myotonias and primary periodic paralyses
Vs. 01
12-10-2011
CASK -linked mental retardation and MICPCH
P398-A1
Vs. 04
25-11-2015
CASK -linked mental retardation and MICPCH